Sam Altman backs Merge Labs, a brain-computer interface startup rivaling Neuralink. With $250M funding, it aims to merge ...

Microsoft (MSFT)-backed OpenAI's latest venture, Merge Labs, is looking to develop a novel gene therapy approach targeting ...

Merge Labs is a new Neuralink rival developing brain-computer interfaces. If you’ve enjoyed Elon Musk’s ongoing beef with ...

Sam Altman is backing brain-computer interface startup Merge Labs to compete with Elon Musk’s Neuralink, aiming to advance human-AI connections.

Microsoft (NASDAQ:MSFT)-backed OpenAI co-founder Sam Altman is gearing up to back Merge Labs, a new brain-computer interface startup that could go head-to-head with Elon Musk's Neuralink, the ...

Sam Altman is reportedly entering in brain-computer interface domain through a new startup, Merge Labs. The company is ...

OpenAI CEO Sam Altman is in talks to co-found Merge Labs, a potential $850M brain–computer interface startup rivaling Elon ...

Sam Altman is planning a brain implant startup to rival Elon Musk’s Neuralink: OpenAI is planning to invest in a brain ...

Sam Altman is launching $850M Merge Labs to rival Musk’s Neuralink, fueling Silicon Valley’s intensifying brain-computer ...

The brain chip company that has drawn interest from Sam Altman and his artificial intelligence business OpenAI is exploring ...

Merge Labs, which aims to develop brain-computer interfaces, is in early talks to raise $250 million at an $850 million valuation from investors including OpenAI, the Financial Times reported. Merge ...

The Financial Times reports today that OpenAI co-founder Sam Altman plans to invest in new brain-computer interface (BCI) venture Merge Labs.